Loading...
Docoh

Wed. 3 Aug 2022, 5:07pm ET Benzinga Earnings, News
Corcept Therapeutics (NASDAQ:CORT) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.21 by 14.29 percent. This is a 20 percent decrease over earnings of $0.30 per share from the same period last year. The company reported quarterly sales of $103.40 million which beat the analyst consensus estimate of $101.00 million by 2.38 percent. This is a 12.90 percent increase over sales of $91.59 million the same period last year.